Dr. Lal PathLabs Limited (LALPATHLAB)

Name: Dr. Lal PathLabs Limited（LALPATHLAB）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Healthcare · ウォール街（米国） · 最終更新: 2026-09-20

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

主要指標

時価総額: ₹317 billion
売上高（2026-03-31 期末の会計年度）: ₹27.6B
当期純利益: ₹5.0B
売上総利益率: 80.6%
純利益率: 18.3%

インタラクティブチャートと全財務諸表を見る →

年次損益計算書

損益計算書	2026-03-31	2025-03-31	2024-03-31	2023-03-31
売上高合計	₹27.6B	₹24.6B	₹22.3B	₹20.2B
売上総利益	₹22.3B	₹19.8B	₹14.6B	₹12.9B
営業利益（EBIT）	₹10.2B	₹9.0B	₹4.7B	₹3.4B
当期純利益	₹5.0B	₹4.9B	₹3.6B	₹2.4B

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は LALPATHLAB のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/LALPATHLAB

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.